{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:37Z","timestamp":1762875997539},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.endinu.2017.12.009","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T09:07:24Z","timestamp":1520327244000},"page":"280-286","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Programa de cribado en cascada para la detecci\u00f3n de la hipercolesterolemia familiar"],"prefix":"10.1016","volume":"65","author":[{"given":"Patricia","family":"Rubio-Mar\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Mich\u00e1n-Do\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Maraver-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Arroyo-Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosal\u00eda","family":"Barrado Varea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldo","family":"P\u00e9rez de Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2017.12.009_bib0145","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial typeII hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation."},{"key":"10.1016\/j.endinu.2017.12.009_bib0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.322.7293.1019","article-title":"Mortality over two centuries in large pedigree with familial hypercholesterolaemia: Family tree mortality study","volume":"322","author":"Sijbrands","year":"2001","journal-title":"BMJ."},{"key":"10.1016\/j.endinu.2017.12.009_bib0155","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/ATVBAHA.116.307514","volume":"36","author":"P\u00e9rez de Isla","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.endinu.2017.12.009_bib0160","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1038\/s41598-017-06101-6","article-title":"Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type2 diabetes in heterozygous familial hypercholesterolemia","volume":"7","author":"Climent","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.endinu.2017.12.009_bib0165","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: Data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med."},{"key":"10.1016\/j.endinu.2017.12.009_bib0170","first-page":"2863","article-title":"Familial hypercholesterolemia","volume":"2","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.endinu.2017.12.009_bib0175","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary artery disease: Consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.endinu.2017.12.009_bib0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCGENETICS.116.001545","article-title":"Homozygous familial hypercholesterolemia in Spain prevalence and phenotype-genotype relationship","volume":"9","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2016","journal-title":"Circ Cardiovasc Genet."},{"key":"10.1016\/j.endinu.2017.12.009_bib0185","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/j.endinu.2017.12.009_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"5","author":"Pedersen","year":"2004","journal-title":"Atheroscler Suppl."},{"key":"10.1016\/j.endinu.2017.12.009_bib0195","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolemia: A long term cohort study","volume":"337","author":"Vermissen","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.endinu.2017.12.009_bib0200","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-Year SAFEHEART registry follow-up","volume":"67","author":"P\u00e9rez de Isla","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.endinu.2017.12.009_bib0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.aprim.2013.12.015","article-title":"Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document","volume":"47","author":"Mata","year":"2015","journal-title":"Aten Primaria."},{"key":"10.1016\/j.endinu.2017.12.009_bib0210","first-page":"182","article-title":"Expert consensus on the detection and clinical management of familial hypercholesterolemia","volume":"25","author":"Masana","year":"2013","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.endinu.2017.12.009_bib0215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.endinu.2017.12.009_bib0220","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART Registry","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.endinu.2017.12.009_bib0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.07.020","article-title":"Cascade screening of familial hypercholesterolemia must go on","volume":"242","author":"Galema-Boers","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.endinu.2017.12.009_bib0230","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.recesp.2014.01.016","article-title":"Screening for familial hypercholesterolemia: A model for preventive medicine","volume":"67","author":"Mata","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.endinu.2017.12.009_bib0235","unstructured":"Fundaci\u00f3n de Hipercolesterolemia Familiar. Madrid: FHF; 2015 [consultado 14 May 2017]. Disponible en: http:\/\/www.colesterolfamiliar.org"},{"key":"10.1016\/j.endinu.2017.12.009_bib0240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1586\/erc.13.7","article-title":"Early diagnosis and treatment of familial hypercholesterolemia: Improving patient outcomes","volume":"11","author":"Alonso","year":"2013","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"10.1016\/j.endinu.2017.12.009_bib0245","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.endinu.2017.12.009_bib0250","unstructured":"World Health Organization. Human Genetic Program. Familial Hypercholesterolemia, a Global Perspective. WHO\/HGN\/FH\/CONS\/99.2. Geneva: World Health Organization; 1999. [consultado 10 May 2017]. Disponible en: http:\/\/apps.who.int\/iris\/handle\/10665\/66346"},{"key":"10.1016\/j.endinu.2017.12.009_bib0255","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"L\u00e1zaro","year":"2017","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.endinu.2017.12.009_bib0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2017.04.002","article-title":"Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry","volume":"262","author":"Bourbon","year":"2017","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.endinu.2017.12.009_bib0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1079\/PHN2002450","article-title":"Using different physical activity measurements in eight European countries. Results of the European Physical Activity Surveillance System (EUPASS) time series survey","volume":"6","author":"R\u00fctten","year":"2003","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.endinu.2017.12.009_bib0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQoL \u2014 a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy."},{"key":"10.1016\/j.endinu.2017.12.009_bib0275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2015.03.002","article-title":"IMPROVE-IT clinical implications. Should the \u201chigh-intensity cholesterol-lowering therapy\u201d strategy replace the \u201chigh-intensity statin therapy\u201d?","volume":"240","author":"Massana","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016418300168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016418300168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T04:36:57Z","timestamp":1570855017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016418300168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2530016418300168"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2017.12.009","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programa de cribado en cascada para la detecci\u00f3n de la hipercolesterolemia familiar","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}